Preimplant Factors Affecting Prostate D90 after Transperineal Interstitial Prostate Brachytherapy with Loose 125I Seeds

DOI Web Site PubMed 参考文献42件 オープンアクセス
  • Sugawara Akitomo
    Department of Radiology, School of Medicine, Keio University, Tokyo, Japan
  • Nakashima Jun
    Department of Urology, Tokyo Medical University, Tokyo, Japan
  • Kunieda Etsuo
    Department of Radiation Oncology, Tokai University School of Medicine, Kanagawa, Japan
  • Nagata Hirohiko
    Department of Urology, School of Medicine, Keio University, Tokyo, Japan
  • Mizuno Ryuichi
    Department of Urology, School of Medicine, Keio University, Tokyo, Japan
  • Takeda Atsuya
    Department of Radiology, Ofuna Chuo Hospital, Kanagawa, Japan
  • Seki Satoshi
    Department of Radiology, School of Medicine, Keio University, Tokyo, Japan
  • Shiraishi Yutaka
    Department of Radiology, School of Medicine, Keio University, Tokyo, Japan
  • Kouta Ryuichi
    Department of Radiology, School of Medicine, Keio University, Tokyo, Japan
  • Oya Mototsugu
    Department of Urology, School of Medicine, Keio University, Tokyo, Japan
  • Shigematsu Naoyuki
    Department of Radiology, School of Medicine, Keio University, Tokyo, Japan

書誌事項

タイトル別名
  • Preimplant Factors Affecting Prostate D90 after Transperineal Interstitial Prostate Brachytherapy with Loose <sup>125</sup>I Seeds

この論文をさがす

説明

The dose received by 90% of the prostate volume (D90) is the key parameter of dosimetric analysis in prostate brachytherapy. The aim of this analysis was to identify preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose 125I seeds. We reviewed the records of 210 patients who underwent transperineal interstitial prostate brachytherapy with loose 125I seeds for clinical T1/T2 prostate cancer at our institution. Patients who received supplemental external-beam radiation therapy were excluded. One hundred and nine patients (51.9%) received neoadjuvant hormonal therapy (NHT). One month after seed implantation, postimplant computed tomography and dosimetric analysis were performed. Univariate and multivariate analyses were carried out to identify preimplant factors affecting postimplant prostate D90. The postimplant prostate D90 values ranged from 123.3 to 234.1 Gy (mean ± standard error, 177.1 ± 1.4 Gy). Postimplant prostate D90 differed significantly between patients who had and had not undergone NHT (P = 0.001). In addition, simple regression analyses showed positive correlations with the estimated preimplant prostate D90, preimplant prostate volume by transrectal ultrasound (TRUS), total radioactivity, number of needles, and number of seeds. On stepwise multiple regression analysis, postimplant prostate D90 showed significant negative correlations with NHT and preimplant prostate volume by TRUS, and a significant positive correlation with total radioactivity. In conclusion, NHT, preimplant prostate volume by TRUS, and total radioactivity are significant preimplant factors affecting postimplant prostate D90 in prostate cancer patients treated with transperineal interstitial prostate brachytherapy with loose 125I seeds.

収録刊行物

参考文献 (42)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ